NovaBridge Biosciences (NBP) Net Income towards Common Stockholders (2019 - 2025)
NovaBridge Biosciences (NBP) recorded Net Income towards Common Stockholders of -$72.86 million in Q4 2025, compared with -$10.84 million a year earlier.
Powered by 
Analysis
NovaBridge Biosciences (NBP) Net Income towards Common Stockholders (2019 - 2025) Analysis & Trends
For FY2025, NovaBridge Biosciences reported Net Income towards Common Stockholders of -$88.34 million.
- Across earlier years, Net Income towards Common Stockholders came in at -$22.23 million in FY2024, -$206.44 million in FY2023, -$363.53 million in FY2022 and -$365.87 million in FY2021.
- The Q4 2025 figure is the lowest quarterly Net Income towards Common Stockholders in data going back to Q3 2019.
- Per Business Quant, the preceding three quarters came in at -$6.83 million (Q3 2025), -$5.5 million (Q2 2025) and -$3.15 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | NovaBridge Biosciences | 149.78 Mn | 149.78 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -72.86 Mn |
| Sep 30, 2025 | -6.83 Mn |
| Jun 30, 2025 | -5.50 Mn |
| Mar 31, 2025 | -3.15 Mn |
| Dec 31, 2024 | -10.84 Mn |
| Sep 30, 2024 | -20.49 Mn |
| Jun 30, 2024 | 25.42 Mn |
| Mar 31, 2024 | -16.32 Mn |
| Dec 31, 2023 | -66.61 Mn |
| Sep 30, 2023 | -33.26 Mn |
| Jun 30, 2023 | -320.00 |
| Dec 31, 2020 | 157.16 Mn |
| Sep 30, 2020 | 1.77 Mn |
| Dec 31, 2019 | -54.14 Mn |
| Sep 30, 2019 | -35.10 Mn |
API Access
NovaBridge Biosciences Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=NBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "NBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=NBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();